daunorubicin has been researched along with African Lymphoma in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (29.27) | 18.7374 |
| 1990's | 10 (24.39) | 18.2507 |
| 2000's | 15 (36.59) | 29.6817 |
| 2010's | 3 (7.32) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, Ö; Genç, DB; Karaman, S; Kebudi, R; Vural, S | 1 |
| Betts, MJ; Bonn, BR; Borkhardt, A; Burkhardt, B; Claviez, A; Damm-Welk, C; Eils, R; Hoell, JI; Klapper, W; Oschlies, I; Richter, J; Rohde, M; Russell, RB; Schlesner, M; Siebert, R; Szczepanowski, M; Zimmermann, M | 1 |
| Bariakh, EA; Gemdzhian, EG; Gubkin, AV; Iliushkina, EA; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Kulikov, SM; Magomedova, AU; Makhinia, VA; Mar'in, DS; Morozova, AK; Obukhova, TN; Samoĭlova, RS; Shevelev, AA; Vorob'ev, AI; Zvonkov, EE | 1 |
| Adaletli, I; Aki, H; Apak, H; Bariş, S; Canbolat, A; Celkan, TT; Doğru, O; Hallac, M; Karaman, S; Kurugoglu, S; Ozdemir, N; Ozdil, M; Ozkan, A; Yildiz, I | 1 |
| Chen, B; Jing, H; Ke, X; Wang, J; Xia, G; Yang, P | 1 |
| Camera, A; Chiurazzi, F; D'Arco, AM; Risitano, AM; Rossi, M; Rotoli, B | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Centurioni, R; Corvatta, L; Leoni, F; Leoni, P; Malerba, L; Marconi, M; Masia, MC; Mele, A; Offidani, M; Scortechini, A | 1 |
| Al-Bakrah, M; Al-Jefri, A; Al-Mahr, M; Al-Musa, A; Belgaumi, AF; El-Solh, H; Osman, L; Osman, M; Saleh, M; Salim, MF | 1 |
| Anaclerico, B; Annino, L; Cimino, G; Cuneo, A; Di Raimondo, F; Elia, L; Fazi, P; Foa, R; Mancini, M; Mandelli, F; Mecucci, C; Pane, F; Recchia, A; Saglio, G; Specchia, G; Vitale, A | 1 |
| Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G | 1 |
| Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ | 1 |
| Bariakh, EA; Chernova, NG; Egorova, EK; Gabeeva, NG; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Lorie, IuIu; Magomedova, AU; Mar'in, DS; Moiseeva, TN; Obukhova, TN; Samoĭlova, RS; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE; Zybunova, EE | 1 |
| Guan, ZZ; He, YJ; Lin, JY; Lui, DG; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ | 1 |
| Fätkenheuer, G; Goekbuget, N; Hentrich, M; Hoelzer, D; Hoffmann, C; Horst, HA; Jaeger, H; Noppeney, R; Plettenberg, A; Stellbrink, HJ; Stoehr, A; Van Lunzen, J; Wolf, E; Wyen, C | 1 |
| Ariola, C; De Gregoris, C; Foà, R; Guarini, A; Mandelli, F; Meloni, G; Mettivier, V; Pastorini, A; Perbellini, O; Pizzolo, G; Pizzuti, M; Vignetti, M; Vitale, A | 1 |
| Anderson, JR; Chilcote, RR; Coccia, P; Exelby, P; Hammond, D; Jenkin, DT; Kersey, J; Kushner, J; Meadows, AT; Siegel, S; Wilson, JF | 1 |
| Auclerc, MF; Bernard, J; Chastang, C; Jacquillat, C; Schaison, G; Weil, M | 1 |
| Bhushan, V; Chandy, M; Dennison, D; Kudva, GC; Srivastava, A | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Adair, S; Camitta, BM; Casper, JT; Civin, CI; Graham, M; Kiefer, G; Lauer, SJ; Leventhal, BG; Mahoney, DH; Shuster, JJ | 1 |
| Cattan, AR; Maung, ZT | 1 |
| Bernácer Borja, M; Cela de Julián, ME; Contra Gómez, T; Díaz Pérez, MA; García Gscheidle, A; Gil López, C; López Pérez, J; Martín Ramos, N; Melero Moreno, C; Torres Valdivieso, MJ; Valverde Moreno, F; Vivanco Martínez, JL | 1 |
| Allouche, M; Bettaieb, A; Grignon, C; Laurent, G; Rousse, A; Vindis, C | 1 |
| Bastard, C; Béné, MC; Callat, MP; Falkenrodt, A; Faure, GC; Garand, R; Kandel, G; Lefranc, MP; Lenormand, B; Lesesve, JF; Maynadié, M; Monconduit, M; Solary, E; Thouret, F; Tilly, H; Vannier, JP | 1 |
| Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
| Baggio, G; Casolari, C; Castelli, M; Cermelli, C; Lupo, L; Malagoli, M; Riccomi, TR; Zanca, A | 1 |
| Abéna, P; Arnoulet, C; Aurran-Schleinitz, T; Bouabdallah, R; Chetaille, B; Coso, D; Dubus, P; Gastaut, JA; Sainty, D; Xerri, L | 1 |
| Botsonis, A; Moschovi, M; Papadopoulou, AL; Tsangaris, GT; Tzortzatou-Stathopoulou, F | 1 |
| Fomicheva, EV; Lazhko, EI; Pomanova, NP; Saburova, TP; Zbarskiĭ, VB | 1 |
| Bartley, MH; Meshul, CK; Myers, SL; Yih, WY | 1 |
| Arkin, H; Holland, JF; Ohnuma, T | 1 |
| Chen, FM; Epstein, AL; LeBerthon, B; Naeve, GS | 1 |
| Badía Torroella, RM; Cubells Riero, J; González Rivero, MA; Illa Sala, J; Melo Valls, M; Pardo García, N; Turmo Martí, J; Vela Ferrer, E | 1 |
| Zubrod, CG | 1 |
| Bailey, I; Kiryabwire, Y; Magrath, IT; Mugerwa, J; Olweny, C | 1 |
| Burchenal, JH; Cole, MT; Dowling, MD | 1 |
| Bodey, GP; Freireich, EJ; Rodriguez, V | 1 |
| Ravina, A | 1 |
| Holland, JF | 1 |
| Henderson, ES | 1 |
4 review(s) available for daunorubicin and African Lymphoma
| Article | Year |
|---|---|
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction | 2004 |
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Infant; Leukemia-Lymphoma, Adult T-Cell; Life Tables; Male; Methotrexate; Neoplasm, Residual; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 2001 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgkin Disease; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Mercaptopurine; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1973 |
[Burkitt's lymphoma and acute leukemias].
Topics: Acute Disease; Animals; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Fluorouracil; Humans; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Oncogenic Viruses; Prednisolone; Prednisone; Vincristine | 1969 |
7 trial(s) available for daunorubicin and African Lymphoma
| Article | Year |
|---|---|
[Efficacy of conservative treatment of gastric lymphosarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2008 |
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Marrow Diseases; Burkitt Lymphoma; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Carriers; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infections; Leukemia, T-Cell; Life Tables; Liposomes; Male; Methotrexate; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Safety; Survival Analysis; Topotecan; Treatment Outcome | 2003 |
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Fusion Proteins, bcr-abl; Genotype; Humans; Male; Middle Aged; Oncogene Proteins, Fusion; Prednisone; Treatment Outcome; Vincristine | 2003 |
Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; China; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Mucositis; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2006 |
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Clinical Trials as Topic; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Random Allocation; Vincristine | 1983 |
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cortisone; Cyclophosphamide; Daunorubicin; Female; Gene Rearrangement, T-Lymphocyte; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Infant; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Neprilysin; Outcome Assessment, Health Care; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Steroids; Vincristine | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
30 other study(ies) available for daunorubicin and African Lymphoma
| Article | Year |
|---|---|
Treatment results of modified BFM protocol in pediatric high-risk Burkitt lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Daunorubicin; Humans; Male; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2021 |
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cohort Studies; Daunorubicin; Female; Humans; Lymphoma, B-Cell; Male; Mutation; Pediatrics; Prednisone; rhoA GTP-Binding Protein; Vincristine | 2014 |
Treatment of pediatric Burkitt lymphoma in Turkey.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisone; Risk Factors; Survival Analysis; Testicular Neoplasms; Turkey; Vincristine | 2010 |
Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Daunorubicin; Doxorubicin; Drug Synergism; Flow Cytometry; Humans; Magnetite Nanoparticles; NF-kappa B; Tumor Suppressor Protein p53 | 2010 |
Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Burkitt Lymphoma; Carrier Proteins; Daunorubicin; Fatal Outcome; Genetic Heterogeneity; Granulocyte Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Intracellular Signaling Peptides and Proteins; Lamivudine; Lenograstim; Liver Failure; Lymphoproliferative Disorders; Male; Mucormycosis; Pleural Effusion; Prednisone; Recombinant Proteins; Signaling Lymphocytic Activation Molecule Associated Protein; Tumor Virus Infections; Vincristine | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Asparaginase; Burkitt Lymphoma; Daunorubicin; Dexamethasone; Drug Therapy, Combination; Humans; Prednisone; Retrospective Studies; Vincristine | 2003 |
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2004 |
[Treatment of adult Berkitt-like lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Daunorubicin; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2005 |
AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Lymphoma, AIDS-Related; Male; Mercaptopurine; Prednisolone; Prednisone; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Burkitt Lymphoma; CD13 Antigens; Cell Lineage; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Sialic Acid Binding Ig-like Lectin 3 | 2007 |
Poor-prognosis acute lymphoblastic leukemias.
Topics: Adolescent; Adult; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Prognosis; Radiotherapy Dosage; Vincristine | 1982 |
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Vincristine | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Hydrocortisone; Infant; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Treatment Failure | 1993 |
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Coloring Agents; Daunorubicin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Idarubicin; Leukemia, Experimental; Male; Mice; Mice, SCID; Multiple Myeloma; Tetrazolium Salts; Toxicity Tests; Tumor Cells, Cultured | 1996 |
[The results of treatment by the Madrid Pediatric Oncology Group according to the BFM protocols in non-Hodgkin's B-cell lymphoma and acute B-cell lymphoblastic leukemia in pediatric patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell; Male; Neoplasm Staging; Prednisone; Spain; Survival Analysis; Vincristine | 1996 |
Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Ceramides; Daunorubicin; DNA, Neoplasm; HL-60 Cells; Humans; Hydrolysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Transduction, Genetic | 1997 |
Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Benzimidazoles; Burkitt Lymphoma; Cell Division; Chlorocebus aethiops; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterovirus B, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vero Cells; Viruses | 2001 |
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Daunorubicin; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, Large B-Cell, Diffuse; Male; Polymerase Chain Reaction; S100 Proteins | 2001 |
[Rubomycins M and N--new anthracycline antibiotics].
Topics: Animals; Burkitt Lymphoma; Cell Division; Daunorubicin; Humans; Leukemia L1210; Leukemia-Lymphoma, Adult T-Cell; Magnetic Resonance Spectroscopy; Mice; Streptomyces; Tumor Cells, Cultured | 1991 |
African Burkitt's lymphoma: case report and light and electron microscopic findings.
Topics: Africa; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Daunorubicin; Humans; Jaw Neoplasms; Male; Methotrexate; Orbital Neoplasms; Prednisone; Remission Induction; Vincristine | 1990 |
Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect).
Topics: Antineoplastic Agents; Bleomycin; Burkitt Lymphoma; Carboplatin; Cell Count; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Mitoxantrone; Organoplatinum Compounds; Vincristine | 1986 |
Daunomycin and doxorubicin Lym-1-drug conjugates for the treatment of malignant lymphomas.
Topics: Antibodies, Monoclonal; Burkitt Lymphoma; Cell Survival; Daunorubicin; Drug Carriers; Humans; In Vitro Techniques; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
[Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
Acute leukemias and Burkitt's lymphoma. Present status of therapy.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Melphalan; Mercaptopurine; Methotrexate; Prednisone; Pregnancy; Vincristine; Wilms Tumor | 1968 |
Intracerebral Burkitt's lymphoma: pathology, clinical features and treatment.
Topics: Adolescent; Allopurinol; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Hydroxyurea; Male; Methotrexate; Neoplasm Metastasis; Papilledema; Prednisolone; Vincristine | 1974 |
Eventual control of clinical leukemia.
Topics: Administration, Oral; Africa; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; United States; Vincristine | 1973 |
Summary: recent advances in the treatment of acute leukemia and Burkitt's tumor.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Nitroso Compounds; Prednisone; Urea; Vincristine | 1967 |
Treatment of acute leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Thioguanine; Time Factors; Vincristine | 1968 |